Covalon Technologies Ltd (COV.V) Quote| Reuters.com
Edition:
United States

Covalon Technologies Ltd (COV.V)

COV.V on TSX Venture Exchange

1.24CAD
24 Jun 2016
Change (% chg)

$-0.03 (-2.36%)
Prev Close
$1.27
Open
$1.21
Day's High
$1.24
Day's Low
$1.20
Volume
36,800
Avg. Vol
18,310
52-wk High
$1.60
52-wk Low
$0.57

COV.V

Chart for COV.V

About

Covalon Technologies Ltd. is a researcher, developer, manufacturer and marketer of medical products intended for wound care, infection management and surgical procedures. The Company's wound care dressing products include ColActive Plus, ColActive Transfer, CovaWound Silicone, CovaWound Silicone Sacrum, CovaWound Foam, CovaWound... (more)
No analyst recommendations are available for COV.V.

Overall

Beta: 0.88
Market Cap(Mil.): $17.88
Shares Outstanding(Mil.): 14.42
Dividend: --
Yield (%): --

Financials

  COV.V Industry Sector
P/E (TTM): -- 30.47 34.11
EPS (TTM): -0.18 -- --
ROI: -30.31 8.47 14.23
ROE: -35.86 12.87 15.46

BRIEF-Covalon Technologies reports Q2 loss per share of C$0.10

* Q2 loss per share C$0.10 Source text for Eikon: Further company coverage:

May 30 2016

BRIEF-Covalon sees products cleared in 8 countries by 2016 end

* Expects to have its products cleared in Mexico, Colombia, Peru, Venezuela, Ecuador, Dominican Republic, Paraguay And Uruguay by end of 2016

May 19 2016

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Wright Reports
$75.00
Provider : GlobalData
$300.00
Provider : Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.